The role of inflammatory cells in fostering pancreatic cancer cell growth and invasion
- PMID: 22969725
- PMCID: PMC3431795
- DOI: 10.3389/fphys.2012.00270
The role of inflammatory cells in fostering pancreatic cancer cell growth and invasion
Abstract
The pancreatic ductal adenocarcinoma (PDAC) microenvironment accommodates a variety of cell types and a plethora of complex interactions between tumor cells, host cells and extracellular matrix (ECM) components. Here we review the role of inflammatory cells, in particular mast cells, myeloid-derived suppressor cells, macrophages, T regulatory cells, T helper cells and neutrophils. The picture that emerges is that of a tumor microenvironment, in which the immune response is actively suppressed, and inflammatory cells contribute in a variety of ways to tumor progression.
Keywords: T helper cells; inflammation; macrophages; mast cells; myeloid-derived suppressor cells; neutrophils; regulatory T cells; stroma.
Figures

Similar articles
-
Pancreatic Tumor Microenvironment.Adv Exp Med Biol. 2020;1296:243-257. doi: 10.1007/978-3-030-59038-3_15. Adv Exp Med Biol. 2020. PMID: 34185297
-
Innate Immunity and Platelets: Unveiling Their Role in Chronic Pancreatitis and Pancreatic Cancer.Cancers (Basel). 2025 May 17;17(10):1689. doi: 10.3390/cancers17101689. Cancers (Basel). 2025. PMID: 40427186 Free PMC article. Review.
-
Neutrophil-Derived Proteases in the Microenvironment of Pancreatic Cancer -Active Players in Tumor Progression.Int J Biol Sci. 2016 Jan 28;12(3):302-13. doi: 10.7150/ijbs.14996. eCollection 2016. Int J Biol Sci. 2016. PMID: 26929737 Free PMC article. Review.
-
Pancreatic Stellate Cells Promote Tumor Progression by Promoting an Immunosuppressive Microenvironment in Murine Models of Pancreatic Cancer.Pancreas. 2020 Jan;49(1):120-127. doi: 10.1097/MPA.0000000000001464. Pancreas. 2020. PMID: 31856087
-
Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.Br J Surg. 2016 Aug;103(9):1189-99. doi: 10.1002/bjs.10187. Epub 2016 Jun 3. Br J Surg. 2016. PMID: 27256393
Cited by
-
Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma.Gastroenterology. 2013 Jun;144(6):1230-40. doi: 10.1053/j.gastro.2012.12.042. Gastroenterology. 2013. PMID: 23622132 Free PMC article. Review.
-
The complex role of macrophages in pancreatic cancer tumor microenvironment: a review on cancer progression and potential therapeutic targets.Discov Oncol. 2024 Aug 26;15(1):369. doi: 10.1007/s12672-024-01256-x. Discov Oncol. 2024. PMID: 39186144 Free PMC article. Review.
-
Novel therapeutic strategies targeting tumor-stromal interactions in pancreatic cancer.Front Physiol. 2013 Nov 11;4:331. doi: 10.3389/fphys.2013.00331. eCollection 2013. Front Physiol. 2013. PMID: 24273517 Free PMC article. Review.
-
Alteration of pancreatic cancer cell functions by tumor-stromal cell interaction.Front Physiol. 2013 Nov 1;4:318. doi: 10.3389/fphys.2013.00318. Front Physiol. 2013. PMID: 24198790 Free PMC article. Review.
-
Focused ultrasound for immuno-adjuvant treatment of pancreatic cancer: An emerging clinical paradigm in the era of personalized oncotherapy.Int Rev Immunol. 2017 Nov 2;36(6):338-351. doi: 10.1080/08830185.2017.1363199. Epub 2017 Sep 29. Int Rev Immunol. 2017. PMID: 28961038 Free PMC article. Review.
References
-
- Beatty G. L., Chiorean E. G., Fishman M. P., Saboury B., Teitelbaum U. R., Sun W., Huhn R. D., Song W., Li D., Sharp L. L., Torigian D. A., O’dwyer P. J., Vonderheide R. H. (2011). CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science 331, 1612–1616 10.1126/science.1198443 - DOI - PMC - PubMed
-
- Bellone G., Turletti A., Artusio E., Mareschi K., Carbone A., Tibaudi D., Robecchi A., Emanuelli G., Rodeck U. (1999). Tumor-associated transforming growth factor-β and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients. Am. J. Pathol. 155, 537–547 - PMC - PubMed
-
- Bhatti I., Peacock O., Lloyd G., Larvin M., Hall R. I. (2010). Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am. J. Surg. 200, 197–203 10.1016/j.amjsurg.2009.08.041 - DOI - PubMed
LinkOut - more resources
Full Text Sources